+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vaccine Adjuvants Market by Delivery Route (Intramuscular, Intranasal, Oral), Formulation (Emulsions, ISCOMs, Liposomes), End User, Vaccine Category - Global Forecast 2025-2030- Product Image
Vaccine Adjuvants Market by Delivery Route (Intramuscular, Intranasal, Oral), Formulation (Emulsions, ISCOMs, Liposomes), End User, Vaccine Category - Global Forecast 2025-2030- Product Image
Sale

Vaccine Adjuvants Market by Delivery Route (Intramuscular, Intranasal, Oral), Formulation (Emulsions, ISCOMs, Liposomes), End User, Vaccine Category - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5675209
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Amid a global rise in emerging pathogens and the pressing demand for advanced immunization, the vaccine adjuvants market is rapidly transforming, fostering innovation and partnerships to meet evolving healthcare needs and support global health security.

Market Snapshot: Vaccine Adjuvants Market Size and Growth

The Vaccine Adjuvants Market grew from USD 884.18 million in 2024 to USD 957.88 million in 2025. It is expected to continue growing at a CAGR of 8.02%, reaching USD 1.40 billion by 2030. This trajectory highlights the expanding role of adjuvants in next-generation vaccine development, propelled by advancements across technology, regulatory frameworks, and cross-sectoral collaborations.

Scope & Segmentation: Defining the Vaccine Adjuvants Landscape

This market covers a robust array of classifications critical for strategic planning and market entry:

  • Delivery Routes: Includes intramuscular, intranasal, oral, and subcutaneous approaches, each offering unique formulation and immunogenicity profiles for targeting diverse patient populations.
  • Formulation Types: Covers emulsions, ISCOMs (immunostimulatory complexes), liposomes, particulates, and saponin complexes, illustrating how novel carriers and adjuvant modulators shape immune outcomes.
  • End User Segments: Encompasses clinics (such as outpatient and specialty hubs), hospitals (public and private), and research institutes (governmental and private laboratories), reflecting differing procurement and innovation priorities.
  • Vaccine Categories: Includes bacterial, DNA, mRNA, recombinant, and viral vaccine platforms, each with distinct compatibility and development pathways for adjuvant integration.
  • Regional Markets: Americas (including US states like California and Texas, as well as Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (notably UK, Germany, France, Saudi Arabia, South Africa, and others), and Asia-Pacific (such as China, India, Japan, Australia, and Southeast Asian hubs).
  • Leading Companies: Strategic focus by entities including GlaxoSmithKline plc, Merck & Co., Sanofi S.A., CSL Limited, Novavax, Dynavax, Takeda, Croda, Evonik, and Pfizer guides competitive positioning and innovation flows.

Key Takeaways: Strategic Insights and Emerging Trends

  • The vaccine adjuvants market is defined by rapid adoption of molecular design and computational immunology, allowing targeted immune modulation matched to specific diseases or population needs.
  • Partnerships across industry, academia, and public sector organizations are critical in driving evaluation standards, sharing data, and accelerating innovation in adjuvant research and development.
  • Global regulatory agencies are transitioning towards adaptive approval pathways that streamline innovation while maintaining focus on safety and compliance for novel adjuvant technologies.
  • Regional divergence in research priorities underscores the importance of localized adjuvant development, from next-generation innovation in North America to capacity building in sub-Saharan Africa.
  • Segmentation by delivery route, formulation, and vaccine category reveals opportunities for tailored solutions, supporting the advancement of personalized immunotherapies and enhancing vaccine access worldwide.

Tariff Impact: Navigating Supply Chain and Competitive Shifts

The introduction of United States tariffs in 2025 has influenced sourcing strategies, with increased raw material costs prompting manufacturers to diversify suppliers and focus on regional production. This creates added scrutiny on cross-border partnerships and a shift towards localized manufacturing, which may realign global competitive dynamics and require robust compliance frameworks to ensure operational resilience and uninterrupted vaccine supply.

Methodology & Data Sources

This report leverages a rigorous research process, combining expert interviews with data from clinical pipelines, manufacturing capabilities, and peer-reviewed literature. Triangulation of multiple data sources and external peer reviews ensures findings are validated, unbiased, and aligned with evolving industry realities.

Why This Report Matters: Actionable Value for Decision-Makers

  • Enables senior leaders to identify growth areas and technology opportunities across all market segments, ensuring effective positioning against competitive and regulatory shifts.
  • Provides clear, actionable intelligence for mitigating tariff-related and supply chain risks while capturing new value through innovation and regional collaboration.
  • Supports informed decision-making by offering comprehensive analysis on segmentation, emerging platforms, and partnership strategies within the evolving vaccine adjuvants market.

Conclusion

As vaccine adjuvant development accelerates, strategic integration of scientific, regulatory, and operational insights is crucial for market success. Timely adoption of emerging technologies and collaborative practices will drive progress and strengthen preparedness against future health challenges.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of lipid nanoparticle adjuvants in mRNA vaccine platforms to enhance immunogenicity
5.2. Expansion of TLR agonist-based adjuvant formulations targeting innate immune activation in diverse vaccine candidates
5.3. Development of thermostable oil-in-water emulsion adjuvants for improved distribution in low-resource settings
5.4. Adoption of saponin-derived QS-21 adjuvant matrices for next-generation recombinant protein vaccines
5.5. Emergence of CpG oligonucleotide adjuvants for enhancing Th1-biased responses in infectious disease vaccines
5.6. Advancement of mucosal adjuvant delivery systems to support needle-free vaccine administration strategies
5.7. Regulatory convergence efforts facilitating accelerated approval pathways for novel vaccine adjuvant combinations
5.8. Integration of artificial intelligence-driven adjuvant formulation design to tailor antigen presentation profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vaccine Adjuvants Market, by Delivery Route
8.1. Introduction
8.2. Intramuscular
8.3. Intranasal
8.4. Oral
8.5. Subcutaneous
9. Vaccine Adjuvants Market, by Formulation
9.1. Introduction
9.2. Emulsions
9.3. ISCOMs
9.4. Liposomes
9.5. Particulates
9.6. Saponin Complexes
10. Vaccine Adjuvants Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. Outpatient Clinics
10.2.2. Specialty Clinics
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Research Institutes
10.4.1. Government Institutes
10.4.2. Private Laboratories
11. Vaccine Adjuvants Market, by Vaccine Category
11.1. Introduction
11.2. Bacterial Vaccines
11.3. DNA Vaccines
11.4. mRNA Vaccines
11.5. Recombinant Vaccines
11.6. Viral Vaccines
12. Americas Vaccine Adjuvants Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Vaccine Adjuvants Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Vaccine Adjuvants Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. GlaxoSmithKline plc
15.3.2. Merck & Co., Inc.
15.3.3. Sanofi S.A.
15.3.4. CSL Limited
15.3.5. Dynavax Technologies Corporation
15.3.6. Novavax, Inc.
15.3.7. Takeda Pharmaceutical Company Limited
15.3.8. Croda International Plc
15.3.9. Evonik Industries AG
15.3.10. Pfizer Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VACCINE ADJUVANTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VACCINE ADJUVANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. VACCINE ADJUVANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. VACCINE ADJUVANTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. VACCINE ADJUVANTS MARKET: RESEARCHAI
FIGURE 24. VACCINE ADJUVANTS MARKET: RESEARCHSTATISTICS
FIGURE 25. VACCINE ADJUVANTS MARKET: RESEARCHCONTACTS
FIGURE 26. VACCINE ADJUVANTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VACCINE ADJUVANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VACCINE ADJUVANTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VACCINE ADJUVANTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY INTRANASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY EMULSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY EMULSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ISCOMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY ISCOMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY LIPOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PARTICULATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PARTICULATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN COMPLEXES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY SAPONIN COMPLEXES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PRIVATE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY PRIVATE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY BACTERIAL VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY DNA VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY MRNA VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY MRNA VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VACCINE ADJUVANTS MARKET SIZE, BY VIRAL VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES VACCINE ADJUVANTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 102. CANADA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 103. CANADA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 104. CANADA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 105. CANADA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. CANADA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. CANADA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 108. CANADA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 109. CANADA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. CANADA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. CANADA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 112. CANADA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 113. CANADA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 114. CANADA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 115. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 122. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 123. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 125. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 126. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 127. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 128. MEXICO VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA VACCINE ADJUVANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 187. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 188. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 189. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 190. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 191. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 194. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 195. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 196. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 197. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 198. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 199. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 200. GERMANY VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 201. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 202. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 203. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 204. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 205. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 208. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 209. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 210. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 211. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 212. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 213. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 214. FRANCE VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 229. ITALY VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 230. ITALY VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 231. ITALY VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 232. ITALY VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 233. ITALY VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. ITALY VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. ITALY VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 236. ITALY VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 237. ITALY VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 238. ITALY VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 239. ITALY VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 240. ITALY VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 241. ITALY VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 242. ITALY VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 243. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 244. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 245. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 246. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 247. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 250. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 251. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 254. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 255. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 256. SPAIN VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 299. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 300. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 301. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 302. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 303. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 306. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 307. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 308. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 309. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 310. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 311. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 312. DENMARK VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 325. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 326. NETHERLANDS VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 327. QATAR VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 328. QATAR VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 329. QATAR VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 330. QATAR VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 331. QATAR VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. QATAR VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. QATAR VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 334. QATAR VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 335. QATAR VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 336. QATAR VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 337. QATAR VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 338. QATAR VACCINE ADJUVANTS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 339. QATAR VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2018-2024 (USD MILLION)
TABLE 340. QATAR VACCINE ADJUVANTS MARKET SIZE, BY VACCINE CATEGORY, 2025-2030 (USD MILLION)
TABLE 341. FINLAND VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 342. FINLAND VACCINE ADJUVANTS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 343. FINLAND VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 344. FINLAND VACCINE ADJUVANTS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 345. FINLAND VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. FINLAND VACCINE ADJUVANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. FINLAND VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 348. FINLAND VACCINE ADJUVANTS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 349. FINLAND VACCINE ADJUVANTS MARKET SIZE, BY HOSPITALS,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Vaccine Adjuvants market report include:
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Sanofi S.A.
  • CSL Limited
  • Dynavax Technologies Corporation
  • Novavax, Inc.
  • Takeda Pharmaceutical Company Limited
  • Croda International Plc
  • Evonik Industries AG
  • Pfizer Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 957.88 Million
Forecasted Market Value ( USD ) by 2030 $ 1400 Million
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type, By Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type, By Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine, Type - Global Forecast to 2029 - Product Image

Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine, Type - Global Forecast to 2029

  • Report
  • 389 Pages
  • Global
From
Vaccine Adjuvants Market Report 2025 - Product Image

Vaccine Adjuvants Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Vaccine Adjuvants Market Report by Product Type, Route of Administration, Diseases, Application, and Region 2024-2032 - Product Image

Vaccine Adjuvants Market Report by Product Type, Route of Administration, Diseases, Application, and Region 2024-2032

  • Report
  • 136 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.